Iwamae Masayoshi, Takahashi Shinji, Terai Hidetomi, Tamai Koji, Hoshino Masatoshi, Kobayashi Yuto, Umano Masayuki, Sasaki Ryo, Uematsu Masato, Katsuda Hiroshi, Shimada Nagakazu, Nakamura Hiroaki
Department of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Department of Orthopaedic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Spine J. 2024 Dec;24(12):2343-2355. doi: 10.1016/j.spinee.2024.08.002. Epub 2024 Aug 13.
Orthotic treatment is a common option for the conservative treatment of osteoporotic vertebral fractures (OVF). However, there is insufficient evidence of its clinical benefit.
To investigate the effectiveness of orthotic treatment for OVF.
STUDY DESIGN/SETTING: Retrospective cohort study with data from two prospective studies.
This study included 160 patients with fresh OVF enrolled in 2012 and 2020 prospective cohort studies.
The visual analog scale (VAS) score for low back pain was used for clinical outcomes, and radiographic parameters included the percent height of the vertebra and angular change of the vertebral body. Moreover, the occurrence of secondary vertebral fractures was followed-up over time.
The patients were divided into brace and no-brace groups and were matched according to propensity score for age, sex, anterior percent height at the initial examination, and presence of old OVFs. Hazard ratio for the cumulative incidence of secondary vertebral fractures with and without bracing were calculated and analyzed using the generalized Wilcoxon test. In addition, the brace group was divided into soft and rigid brace groups and compared with the no-brace group.
Each group had 61 cases after propensity score matching. There were no significant differences in the VAS improvement for low back pain and the change in percent height of the anterior and posterior walls from initial examination to 6 months after injury (p=.87, p=.39 and p=.14, respectively, mixed-effect models). Meanwhile, the mean angular change of fractured vertebrae was 4.3° / 3.2° initially and 1.2° / 2.5° at 6 months (the brace group / no-brace group, respectively; p=.007, mixed-effect models). A significant difference was also observed between the rigid brace group and the no-brace group (p=.008, mixed effect models). The incidence of secondary vertebral fractures was 1.6% / 11.4% at 1 month, indicating a significant difference (the brace group / no-brace group, respectively; p=.028). The hazard ratio for the cumulative incidence of secondary fractures due to orthotic treatment was 0.47 (95% confidence interval 0.20-1.09, p=.054).
Although orthotic treatment for fresh OVF did not relieve pain, it might contribute to the stabilization of the fractured vertebra, especially using a rigid brace. Moreover, it might influence a reduction of the imminent vertebral fracture risk immediately after the onset of OVF.
Clinical study.
矫形治疗是骨质疏松性椎体骨折(OVF)保守治疗的常见选择。然而,其临床益处的证据不足。
探讨矫形治疗对OVF的有效性。
研究设计/地点:回顾性队列研究,数据来自两项前瞻性研究。
本研究纳入了2012年和2020年前瞻性队列研究中的160例新鲜OVF患者。
采用下腰痛视觉模拟量表(VAS)评分评估临床结局,影像学参数包括椎体高度百分比和椎体角度变化。此外,随访继发性椎体骨折的发生情况。
将患者分为支具组和无支具组,并根据年龄、性别、初次检查时的前侧高度百分比和陈旧性OVF的存在情况进行倾向评分匹配。计算并使用广义Wilcoxon检验分析有支具和无支具情况下继发性椎体骨折累积发生率的风险比。此外,将支具组分为软支具组和硬支具组,并与无支具组进行比较。
倾向评分匹配后每组有61例。从初次检查到受伤后6个月,下腰痛的VAS改善情况以及前后壁高度百分比的变化在两组间无显著差异(分别为p = 0.87、p = 0.39和p = 0.14,混合效应模型)。同时,骨折椎体的平均角度变化在初始时为4.3°/3.2°,6个月时为1.2°/2.5°(分别为支具组/无支具组;p = 0.007,混合效应模型)。硬支具组和无支具组之间也观察到显著差异(p = 0.008,混合效应模型)。1个月时继发性椎体骨折的发生率为1.6%/11.4%,差异有统计学意义(分别为支具组/无支具组;p = 0.028)。矫形治疗导致继发性骨折累积发生率的风险比为0.47(95%置信区间0.20 - 1.09,p = 0.054)。
虽然新鲜OVF的矫形治疗不能缓解疼痛,但可能有助于骨折椎体的稳定,尤其是使用硬支具时。此外,它可能会降低OVF发病后立即发生椎体骨折的风险。
临床研究。